These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30938036)

  • 21. Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial.
    Renard E; Riveline JP; Hanaire H; Guerci B;
    Diabetes Obes Metab; 2022 May; 24(5):859-867. PubMed ID: 34984786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico Study.
    Campos-Náñez E; Breton MD
    J Diabetes Sci Technol; 2017 Nov; 11(6):1196-1206. PubMed ID: 28560900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor.
    Sanchez P; Ghosh-Dastidar S; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2019 Dec; 21(12):677-681. PubMed ID: 31385732
    [No Abstract]   [Full Text] [Related]  

  • 24. Performance of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System in Pediatric Participants With Type 1 Diabetes.
    Welsh JB; Zhang X; Puhr SA; Johnson TK; Walker TC; Balo AK; Price D
    J Diabetes Sci Technol; 2019 Mar; 13(2):254-258. PubMed ID: 30198331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Three-Way Accuracy Comparison of the Dexcom G5, Abbott Freestyle Libre Pro, and Senseonics Eversense Continuous Glucose Monitoring Devices in a Home-Use Study of Subjects with Type 1 Diabetes.
    Jafri RZ; Balliro CA; El-Khatib F; Maheno MM; Hillard MA; O'Donovan A; Selagamsetty R; Zheng H; Damiano ER; Russell SJ
    Diabetes Technol Ther; 2020 Nov; 22(11):846-852. PubMed ID: 32453604
    [No Abstract]   [Full Text] [Related]  

  • 26. Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
    Tweden KS; Deiss D; Rastogi R; Addaguduru S; Kaufman FR
    Diabetes Technol Ther; 2020 May; 22(5):422-427. PubMed ID: 31697182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart algorithm, a 1-hour warm-up time.
    Geoffrey M; Brazg R; Richard W
    J Diabetes Sci Technol; 2011 Jan; 5(1):99-106. PubMed ID: 21303631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance.
    Boscari F; Vettoretti M; Cavallin F; Amato AML; Uliana A; Vallone V; Avogaro A; Facchinetti A; Bruttomesso D
    J Endocrinol Invest; 2022 Jan; 45(1):115-124. PubMed ID: 34196924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance characterization of an abiotic and fluorescent-based continuous glucose monitoring system in patients with type 1 diabetes.
    Mortellaro M; DeHennis A
    Biosens Bioelectron; 2014 Nov; 61():227-31. PubMed ID: 24906080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The accuracy and efficacy of real-time continuous glucose monitoring sensor in Chinese diabetes patients: a multicenter study.
    Zhou J; Lv X; Mu Y; Wang X; Li J; Zhang X; Wu J; Bao Y; Jia W
    Diabetes Technol Ther; 2012 Aug; 14(8):710-8. PubMed ID: 22853722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Interstitial Fluid Glucose Levels Obtained by Continuous Glucose Monitoring and Flash Glucose Monitoring in Patients With Type 2 Diabetes Mellitus Undergoing Hemodialysis.
    Yajima T; Takahashi H; Yasuda K
    J Diabetes Sci Technol; 2020 Nov; 14(6):1088-1094. PubMed ID: 31625413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.
    Irace C; Cutruzzolà A; Nuzzi A; Assaloni R; Brunato B; Pitocco D; Tartaglione L; Di Molfetta S; Cignarelli A; Laviola L; Citro G; Lovati E; Gnasso A; Tweden KS; Kaufman FR
    Diabetes Obes Metab; 2020 Jul; 22(7):1056-1061. PubMed ID: 32037699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study.
    Deiss D; Irace C; Carlson G; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2020 Jan; 22(1):48-52. PubMed ID: 31418587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of the Long-Term Implantable Senseonics Continuous Glucose Monitoring System and Other Continuous Glucose Monitoring Systems.
    Joseph JI
    J Diabetes Sci Technol; 2021 Jan; 15(1):167-173. PubMed ID: 32345047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Prospective Multicenter Clinical Performance Evaluation of the C-CGM System.
    Rebec M; Cai K; Dutt-Ballerstadt R; Anderson E
    J Diabetes Sci Technol; 2022 Mar; 16(2):390-396. PubMed ID: 33084416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator.
    Shah VN; Laffel LM; Wadwa RP; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):428-433. PubMed ID: 29923775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis.
    Ng JKC; Ling J; Luk AOY; Lau ESH; Ma RCW; Li PKT; Szeto CC; Chan JCN; Chow E
    Diabetes Care; 2023 Jun; 46(6):1191-1195. PubMed ID: 37043824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy.
    Irace C; Cutruzzolà A; Tweden K; Kaufman FR
    Expert Rev Med Devices; 2021 Oct; 18(10):909-914. PubMed ID: 34528851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability of Implantable Continuous Glucose Monitoring Sensor.
    Barnard KD; Kropff J; Choudhary P; Neupane S; Bain SC; Kapitza C; Forst T; Link M; Mdingi C; DeVries JH
    J Diabetes Sci Technol; 2018 May; 12(3):634-638. PubMed ID: 28990436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.